CD4 and myeloid sarcoma: To elucidate the immunomodulatory potential of MSC-derived exosomes on MS patients, for the first time the present study aimed to evaluate suppression efficacy of both MSCs and MSC-derived exosomes on proliferation and cytokine production of the CD4+CD25− conventional T cells (Tconv) isolated from RRMS patients and healthy controls.